Charles River Laboratories (CRL) said Wednesday it and Medipost have signed a memorandum of understanding to collaborate on GMP-compliant testing.
Financial terms weren't disclosed.
Under the MoU, Charles River will offer its services related to biologics quality control, viral testing, release testing, and other GMP-compliant services for the support of Medipost's cell therapy pipeline, the company said.